首页 | 本学科首页   官方微博 | 高级检索  
     


Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised,open-label,phase 3 trial
Authors:Prof Jesus San Miguel  Katja Weisel  Philippe Moreau  Martha Lacy  Kevin Song  Michel Delforge  Lionel Karlin  Hartmut Goldschmidt  Anne Banos  Albert Oriol  Adrian Alegre  Christine Chen  Michele Cavo  Laurent Garderet  Valentina Ivanova  Joaquin Martinez-Lopez  Andrew Belch  Antonio Palumbo  Stephen Schey  Pieter Sonneveld  Xin Yu  Lars Sternas  Christian Jacques  Mohamed Zaki  Meletios Dimopoulos
Affiliation:1. Hospital e Instituto Biosanitario de Salamanca (IBSAL), Universidad de Salamanca (IBMCC/CSIC), Salamanca, Spain;2. Clinica Universidad de Navarra, Pamplona, Spain;3. University Hospital Tübingen, Tübingen, Germany;4. University Hospital Hotel-Dieu, Nantes, France;5. Mayo Clinic, Rochester, MN, USA;6. Vancouver General Hospital, Vancouver, BC, Canada;g University Hospital Leuven, Leuven, Belgium;h Centre Hospitalier Lyon Sud/Hospices Civils de Lyon, Pierre-Bénite, France;i University Hospital, Heidelberg, Germany;j Centre Hospitalier de la Côte Basque, Bayonne, France;k Institut Catala d''Oncologia, Hospital Germans Trias i Pujol, Barcelona, Spain;l Hospital Universitario La Princesa, Madrid, Spain;m Princess Margaret Hospital, Toronto, ON, Canada;n Institute of Hematology Seràgnoli, S Orsola''s University Hospital, Bologna, Italy;o Université Pierre et Marie Curie, Paris VI, Hôpital Saint Antoine, Paris, France;p GUZ Moscow City Clinical Hospital S P Botkin, Moscow, Russia;q Hospital Universitario 12 de Octubre, Madrid, Spain;r University of Alberta, Edmonton, AB, Canada;s University of Turin, Turin, Italy;t King''s College Hospital, London, UK;u Erasmus Medical Center, Rotterdam, Netherlands;v Celgene Corporation, Summit, NJ, USA;w Alexandra Hospital, Athens, Greece
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号